Lungs

Lungs; Transplant

Why lung transplant rejection is more normal – and treatable – than most think

Acute rejection of a lung transplant is surprisingly normal; 40 to 50 percent of transplant patients deal with it during the first year after surgery. Discover why UT Southwestern says these rejections are very treatable through medication at home or at the doctor’s office.

• Fernando Torres, M.D.

October 11, 2018

Cancer; Lungs

Lung cancer in young nonsmokers is on the rise: Uncovering the cause

U.S #lungcancer rates have declined for decades, except in one group: Young adults who never smoked. UT Southwestern discusses what we know about the risks, as well as ongoing research to reveal more answers.

• Jonathan Dowell, M.D.

March 12, 2021

COVID; Lungs; Prevention

Life cycle of a coronavirus: How respiratory illnesses harm the body

How can a microscopic respiratory infection such as COVID-19 wreak such havoc in the body so quickly? And why do some patients get hit harder than others. UT Southwestern discusses how a coronavirus can progress in our respiratory tracts.

• Sonja Bartolome, M.D.

April 2, 2020

Cancer; Lungs

Not a cure, but an extension: How immunotherapy works for advanced lung cancer

Data released in April 2018 suggest that adding immunotherapy to chemotherapy can extend the lives of some advanced lung cancer patients. Discover how immunotherapy works and who might benefit.

May 3, 2018